Zydus Lifesciences Ahmedabad oncology injectable plant gets two FDA observations
Zydus clarified that the observations received were minor and unrelated to data integrity. Shares of Zydus Lifesciences Ltd ended at ₹957.80, down by ₹1.10, or 0.11%, on the BSE.

What's Your Reaction?






